POORLY DIFFERENTIATED THYROID CANCER
Clinical trials for POORLY DIFFERENTIATED THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new POORLY DIFFERENTIATED THYROID CANCER trials appear
Sign up with your email to follow new studies for POORLY DIFFERENTIATED THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug zanzalintinib aims to shrink thyroid tumors before surgery
Disease control Recruiting nowThis phase 2 trial tests the drug zanzalintinib given before surgery in 45 people with advanced thyroid cancer. The goal is to see if the drug can shrink tumors, making surgery more effective. Researchers will also monitor safety and side effects.
Matched conditions: POORLY DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New PET scan could improve detection of metastatic thyroid cancer
Diagnosis Recruiting nowThis study compares a newer type of scan (I-124 PET/CT) to the standard scan (I-123 whole body imaging) for finding thyroid cancer that has spread. About 62 people with thyroid cancer will get both scans, and researchers will see if the new scan is more accurate. The goal is to i…
Matched conditions: POORLY DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks thyroid cancer patients outside clinical trials
Knowledge-focused Recruiting nowThis study observes adults with advanced thyroid cancer who are receiving standard treatments in real-world settings, not in clinical trials. Researchers aim to understand barriers to accessing care and how well patients tolerate and respond to available medications. About 459 pa…
Matched conditions: POORLY DIFFERENTIATED THYROID CANCER
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC